Resmed (RMD) Depreciation & Amortization (IS) (2021 - 2025)
Resmed (RMD) has disclosed Depreciation & Amortization (IS) for 5 consecutive years, with $49.9 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Depreciation & Amortization (IS) rose 7.42% year-over-year to $49.9 million, compared with a TTM value of $204.9 million through Dec 2025, up 14.9%, and an annual FY2025 reading of $198.5 million, up 12.21% over the prior year.
- Depreciation & Amortization (IS) was $49.9 million for Q4 2025 at Resmed, up from $47.7 million in the prior quarter.
- Across five years, Depreciation & Amortization (IS) topped out at $63.6 million in Q2 2025 and bottomed at $36.3 million in Q3 2022.
- Average Depreciation & Amortization (IS) over 5 years is $43.9 million, with a median of $43.7 million recorded in 2024.
- The sharpest move saw Depreciation & Amortization (IS) decreased 7.41% in 2022, then soared 45.68% in 2025.
- Year by year, Depreciation & Amortization (IS) stood at $40.8 million in 2021, then fell by 7.41% to $37.8 million in 2022, then increased by 18.58% to $44.8 million in 2023, then rose by 3.7% to $46.4 million in 2024, then increased by 7.42% to $49.9 million in 2025.
- Business Quant data shows Depreciation & Amortization (IS) for RMD at $49.9 million in Q4 2025, $47.7 million in Q3 2025, and $63.6 million in Q2 2025.